| 39.8901 -0.02 (-0.05%) | 06-18 10:22 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 48 | 1-year : | 56.06 |
| Resists | First : | 41.09 | Second : | 48 |
| Pivot price | 40.13 |
|||
| Supports | First : | 39.46 | Second : | 38.45 |
| MAs | MA(5) : | 40.3 |
MA(20) : | 40.01  |
| MA(100) : | 39.72 |
MA(250) : | 37.72 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 47.8 |
D(3) : | 57.7 |
| RSI | RSI(14): 52.4 |
|||
| 52-week | High : | 41.9 | Low : | 32.77 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ BME ] has closed above bottom band by 45.0%. Bollinger Bands are 1.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 40.51 - 40.75 | 40.75 - 40.94 |
| Low: | 39.31 - 39.64 | 39.64 - 39.88 |
| Close: | 39.49 - 39.96 | 39.96 - 40.32 |
The BlackRock Health Sciences Trust functions as a closed-end equity investment fund, initiated by BlackRock, Inc. and overseen by BlackRock Advisors, LLC. This trust primarily allocates capital to publicly traded companies within the United States' health sciences and related sectors. Its investment scope includes entities engaged in the research, development, production, distribution, or delivery of medical, dental, optical, pharmaceutical, or biotechnology products, supplies, equipment, or services. Furthermore, the fund employs equity derivatives, with a notable focus on writing options. Its portfolio's performance is gauged against the Russell 3000 Healthcare Index. Established on March 31, 2005, the fund is domiciled in the United States.
Sat, 13 Jun 2026
Avoiding Lag: Real-Time Signals in (BME) Movement - Stock Traders Daily
Thu, 04 Jun 2026
BlackRock Health Sciences Trust announces Monthly dividend, payable on September 30, 2026 - marketscreener.com
Thu, 04 Jun 2026
BlackRock Health Sciences Trust announces Monthly dividend, payable on August 31, 2026 - marketscreener.com
Thu, 04 Jun 2026
BlackRock Health Sciences Trust announces Monthly dividend, payable on July 31, 2026 - marketscreener.com
Mon, 25 May 2026
BlackRock Health Sciences Trust - INDmoney
Fri, 22 May 2026
BME: Discount Narrows, But A Strong Long-Term Hold Candidate Anyway - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 13 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 20.5 (%) |
| Shares Short | 51 (K) |
| Shares Short P.Month | 66 (K) |
| EPS | 5.92 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 43.97 |
| Profit Margin | 994.9 % |
| Operating Margin | 20.2 % |
| Return on Assets (ttm) | 0.1 % |
| Return on Equity (ttm) | 13.8 % |
| Qtrly Rev. Growth | 7.5 % |
| Gross Profit (p.s.) | 0.59 |
| Sales Per Share | 0.59 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 55 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | 6.76 |
| PEG Ratio | 0 |
| Price to Book value | 0.91 |
| Price to Sales | 66.83 |
| Price to Cash Flow | 9.47 |
| Dividend | 0.25 |
| Forward Dividend | 0 |
| Dividend Yield | 0.6% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|